HIV / AIDS in the News

Merck's oral HIV treatment as effective as Gilead's Biktarv - The Jerusalem Post

 

Ripple effects of Penobscot County's HIV outbreak are spreading throughout Maine - WGME

 

Millions of lives at risk from HIV, TB and malaria funding cuts - The Independent

 

World AIDS Day: Health Department Offers Free, Confidential HIV Testing Dec. 1 - Your Ohio News

 

Targeting of specific CCR5-G protein complexes underlies biased signaling by HIV-1 envelope glycoproteins - Cell Communication and Signaling

 

China pledges $3.49M to support HIV prevention efforts in South Africa - Anadolu Ajansı

 

CaixaForum+ and IrsiCaixa present RED, a documentary that weaves connections between science, memory and the future of HIV - Atalayar

 

Ripple effects of Penobscot County's HIV outbreak are spreading throughout Maine - Philanthropy News Digest

 

WHO launches new framework to tackle drug resistance to HIV, hepatitis B and C, and STIs - World Health Organization (WHO)

 

2025 Archives - New Study Identifies Key Mechanism Driving HIV-Associated Immune Suppression - Maryland School of Medicine

 

UToledo to Host Events Marking World AIDS Day - UToledo News

 

Ripple effects of Penobscot County’s HIV outbreak are spreading throughout Maine - Bangor Daily News

 

How people's love for Freddie Mercury helped overcome fear of HIV - Big Issue

 

Interview with Esteban Martinez: EACS Guideline updates - European AIDS Treatment Group

 

Switching to doravirine maintains viral suppression in HIV-1 - European AIDS Treatment Group

 

CD16+ monocytes are the first responders to HIV reactivation - European AIDS Treatment Group

 

HIV-1 vaccine triggers sex-based antibody differences - European AIDS Treatment Group

 

Dr. Daniel Driffin breaks silence on HIV misconceptions - Rolling Out

 

Joyride event from Orlando to St. Pete raises funds for HIV services - Bay News 9

 

Six-month study finds exercise and stretching beneficial for brain and body in people with HIV - European AIDS Treatment Group

 

Systemic inflammation in suppressed HIV similar after switch to 3-drug ART - European AIDS Treatment Group

 

Merck announces results from Phase 3 trial evaluating doravirine/islatravir - European AIDS Treatment Group

 

Non-AIDS cancer risk drops considerably when ART is initiated within a year of HIV acquisition - European AIDS Treatment Group

 

No seat at the table for Botswana’s NGOs - European AIDS Treatment Group

 

South Africa may be excluded from future US grants for HIV amid political row; China unveils US$ 3.49 million HIV prevention support for South Africa - European AIDS Treatment Group

 

Low doses of THC can help reduce side effects from HIV treatment, study shows - Straight Arrow News

 

“Elite controllers” provide clues for an HIV cure strategy - European AIDS Treatment Group

 

Control of HIV, TB and malaria at risk after global health fund donations fall - The Guardian

 

First Deliveries of Gilead's Twice-Yearly HIV Prevention Therapy in Sub-Saharah Africa - and What it Means for Ending the HIV Epidemic - Gilead Sciences

 

First Deliveries of Gilead's Twice-Yearly HIV Prevention Therapy in Sub-Saharan Africa – and What it Means for Ending the HIV Epidemic - Gilead Sciences